MOTS C Research Protocol Reference
A compilation of published research protocol parameters. For laboratory reference only — not a protocol recommendation.
⚠ FOR RESEARCH REFERENCE ONLY — NOT A PROTOCOL RECOMMENDATION. This page summarizes published research parameters and does not constitute guidance for human use. No validated human protocols exist for MOTS C. All data derives from preclinical studies. See our full disclaimer.
Protocol Overview
FOR RESEARCH REFERENCE ONLY - This document summarizes research protocols investigating MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-Type-c), a mitochondrial-derived peptide. Studies suggest MOTS-c may influence metabolic regulation and cellular aging processes (PMID: 25565208). All information is for academic reference only and should never be used as medical recommendations. Researchers have explored MOTS-c's potential role in metabolic homeostasis and longevity pathways, though human applications remain investigational.
Administration & Routes
Research protocols have primarily utilized subcutaneous injection routes in animal models. Studies suggest subcutaneous administration provides systemic bioavailability despite MOTS-c's short plasma half-life of minutes (PMID: 25565208). Researchers have noted that while plasma clearance is rapid, cellular effects may persist longer than plasma concentrations would suggest. Intraperitoneal and intravenous routes have also been explored in laboratory settings. IMPORTANT: All administration data derives from preclinical research only.
Dosing Schedule Reference
Animal studies have explored dosing ranges of 5-15 mg/kg/day via subcutaneous injection (PMID: 25565208). Research protocols typically investigate daily administration patterns due to the compound's short plasma half-life. Studies suggest dosing frequency may need to account for both pharmacokinetic clearance and duration of cellular effects. WARNING: No human dosing guidelines exist - all data is from animal research only.
Cycling & Duration
Research literature does not establish standardized cycling protocols for MOTS-c. Studies have explored both continuous daily administration and intermittent dosing schedules in animal models. Researchers suggest that cycling patterns may depend on study objectives, whether investigating acute metabolic effects or longer-term aging interventions. CRITICAL: Cycling recommendations are purely theoretical based on limited preclinical data.
Monitoring Parameters
Research protocols monitoring MOTS-c effects have assessed metabolic parameters including glucose tolerance, insulin sensitivity, and mitochondrial function markers. Studies suggest monitoring body weight, metabolic rate, and cellular bioenergetics in research settings (PMID: 25565208). Researchers have explored measuring circulating metabolites and mitochondrial respiratory capacity as outcome measures. ESSENTIAL: No established human monitoring protocols exist.
Combinations & Stacks
Limited research has explored MOTS-c in combination with other longevity-related interventions. Studies suggest potential synergistic effects with caloric restriction and exercise interventions in animal models. Researchers have investigated combinations with other mitochondrial-targeting compounds in laboratory settings. CAUTION: Combination research is extremely preliminary and limited to preclinical studies.